Cambridge Investment Research Advisors’s LifeMD LFMD Stock Holding History
Bought
Maintained
Sold
Other funds holding LFMD
PGCM
BRF
RA
Cambridge Investment Research Advisors's LFMD Position: Q2 2026 in Review
Cambridge Investment Research Advisors held its LifeMD (LFMD) position steady in Q2 2026 at 25,500 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #3927.
Cambridge Investment Research Advisors first reported a position in LFMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $347K in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.
- Cambridge Investment Research Advisors held 25,500 shares of LifeMD worth $105K as of Q2 2026.
- Cambridge Investment Research Advisors left its LifeMD share count unchanged in Q2 2026.
- LifeMD made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3927 holding.
- Cambridge Investment Research Advisors first reported a position in LifeMD in Q4 2021 and has held it in 19 quarters since.
- Cambridge Investment Research Advisors's LifeMD position peaked at $347K in Q2 2025.
- 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.